ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

House Committee Begins Investigation Of NCI’s National Lung Screening Trial.

October 26, 2007

Northwestern To Test Method To Detect Colon Cancer

February 25, 2005

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

March 21, 1997

Also New AACR President Lynn Matrisian plans emphasis on enhancing communication.

April 2, 2004

NCI Director Klausner Resigns To Head Institute Begun By AOL Chairman Case.

September 14, 2001